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a diagnosis of bipolar disorder and received combination therapy
with an atypical antipsychotic and a mood stabilizer. A 2-stage
sample selection model controlled for differences between indi-
viduals receiving antipsychotics and factors that may impact 
the probability of hospitalization, i.e. demographics, bipolar
type, disease severity, comorbidities, mood stabilizer used, and
antipsychotic used. RESULTS: Individuals most likely to be hos-
pitalized were those diagnosed as manic or bipolar depressed, or
were receiving divalproex sodium or gabapentin. In pair-wise
comparisons, hospitalization in the year following the start of
combination antipsychotic therapy was 44% less likely for those
receiving quetiapine vs olanzapine (P = 0.0354). There was no
signiﬁcant difference in the likelihood of hospitalization for 
the quetiapine group compared to the risperidone group (P =
0.5826). CONCLUSIONS: In patients with bipolar disorder
receiving a mood stabilizer plus an atypical antipsychotic, the
probability of hospitalization with quetiapine was signiﬁcantly
lower than with olanzapine, and similar to risperidone. These
ﬁndings are relevant to prescription choices among atypical
antipsychotics, for maximizing patient beneﬁt and minimizing
the burden of disease.
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OBJECTIVE: To assess indirect costs of work loss associated
with bipolar disorder and major (unipolar) depression.
METHOD: From MEDSTAT’s employer-based MarketScan©
database for year 2000, workers (mean age 42 ± 9) with a
primary ICD9-CM diagnosis of bipolar disorder (N = 740),
major depression (N = 6314), and one-to-one matched controls
with no psychiatric diagnosis were identiﬁed. Work loss para-
meters were absence hours and payments for short-term disabil-
ity and worker compensation. RESULTS: Mean annual absence
hours were 55 (±49) for the bipolar group vs 21 (±27) for con-
trols (P = 0.009), and 53 (±154) for the unipolar depression
group vs 24 (±48) for controls (P < 0.0001). Mean short-term
disability payments were $1231 (±3424) for the bipolar group
vs $131 (±967) for controls (P < 0.0001), and $741 (±2873) for
the unipolar depression group vs $178 (±1309) for controls (P <
0.0001). Mean worker compensation payments were $554
(±4231) for the bipolar group vs $228 (±2289) for controls (P =
0.15), and $518 (±4814) for the unipolar depression group 
vs $220 (±2449) for controls (P = 0.0001). CONCLUSIONS:
Bipolar disorder and major (unipolar) depression signiﬁcantly
increased work loss. Patients with bipolar disorder may exhaust
their sick leave and go onto short-term disability more frequently
than those with unipolar depression.
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OBJECTIVE: The Child Health Illness Proﬁle-Child Edition
(CHIP-CE) instrument is a psychometrically sound pediatric
quality of life measure that works well in diverse ethnic and
racial populations. Although the CHIP-CE has been used in a
variety of populations, no known studies have used this instru-
ment to evaluate the quality of life of children with Attention
Deﬁcit/Hyperactivity Disorder (ADHD). Our objective was to
evaluate the quality of life of children using the CHIP-CE in a
population of ADHD patients commonly treated with medica-
tions. METHODS: The CHIP-CE is a 76-item, parent-report
questionnaire that assesses multiple domains of children’s health-
related quality of life including: satisfaction (with self and
health), comfort (emotional and physical symptoms and limita-
tions), resilience (positive activities that promote health), risk
avoidance (risky behavior that inﬂuences future health), and
achievement (of social expectations in school and with peers).
Standard scores (mean = 50, SD = 10) are established. One
hundred thirty people in the United Kingdom (UK) were screened
to ﬁnd 83 eligible parents of children with ADHD to participate
in a survey including the CHIP-CE questionnaire and an ADHD
symptom frequency measure, the ADHD-RS. RESULTS: The
total mean ADHD-RS score (37.2) in the sample was high and
comparable to patients in drug trails (the normative non-ADHD
score ranges from 7.4 to 12.5). The children of the parents rated
had a mean age of 12.6. Seventy-two and three-tenths percent
were currently being treated with stimulants and 97.6% were
currently receiving therapy of either stimulants or psychother-
apy. Children in the sample had considerable impairment in all
5 domains of the CHIP-CE, in particular the risk avoidance
(25.2), achievement (29.1), and satisfaction (28.7) domains.
CONCLUSION: The CHIP-CE assessment shows signiﬁcant
quality of life impairment in this sample of children with ADHD,
despite 70% of the patients being currently treated with 
stimulant medication.
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OBJECTIVE: Mental health disorders among children and ado-
lescents do not have sufﬁcient attention. The purpose of this
study was to assess direct health care costs and drug utilization
for students with mental health illnesses in School-Based Health
Centers (SBHC) and comparable schools. METHODS: Four
SBHC intervention and two comparable non-SBHC schools (dis-
tricts) in Ohio were selected for this study. A total of 1200 stu-
dents who were enrolled in Medicaid program and had at least
one mental illness diagnosis and received mental health medica-
tions were identiﬁed for this cohort. There were 850 students in
those schools with SBHCs, and 350 students in non-SBHCs. The
study period was from August 1997 to August 2002. Repeated
measures analysis of covariates (ANCOVA) was conducted to
assess the adjusted monthly total cost and the monthly mental
health service cost before and after the SBHC program.
RESULTS: The cohort involved 64.8% male, 40.7% African-
American, and average 9.8 (SD 2.65) years-old in September
2001. During the study period, average monthly total costs were
$221 (SD 692) before SBHC and $295 (SD 742) after SBHC.
The most frequently diagnosed mental illnesses for all students
were hyperkinetic syndrome of childhood, adjustment reaction,
disturbance of emotion/conduct, affective psychoses, neurotic
disorders, and speciﬁc delays in development. Frequently pre-
scribed medications were antihyperkinesis agents (4.3 Rx per
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student), anticonvulsants (2.8 Rx/student), adrenergics/amphet-
amine (2.4 Rx/student), antidepressants (2.3 Rx), and antipsy-
chotics (1.9 Rx/student). After controlling for demographics and
Medicaid enrollment status, ANCOVA indicated a signiﬁcant
SBHC intervention effect (Time*SBHC) for both monthly total
cost (F = 8.82, p = 0.003) and monthly mental health service cost
(F = 5.06, p = 0.025). CONCLUSION: The SBHC program that
provides mental health services for students did not decrease the
total Medicaid costs, instead, might increase the health quality
and health care accessibility for students with mental illnesses,
and this hypothesis should be examined in future research.
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OBJECTIVE: Case studies of behavioral carve-outs using
pre/post designs have found that they results in substantial
savings. Prior studies have not, however, examined the impact of
behavioral carve-outs on psychotropic medication usage and
costs. This study ﬁlls this gap. METHODS: Data came from
Medstat’s MarketScan claims database. The sample comprised
ten large employers with and without behavioral carve-outs. The
employers included about 1.4 million employees and their depen-
dents (about 890,000 were enrolled in carve-outs and 521,000
in non-carve-outs). A 2-part model was used to examine differ-
ences in the probably of use and the cost of services among users.
Total costs, inpatient, outpatient, and pharmaceutical costs were
examined. Independent variables included age, gender, diagno-
sis, region, plan type, and plan ﬁxed effects (to control for beneﬁt
design). Predicted expenditures were calculated using the smear-
ing technique. Inpatient and outpatient behavioral health claims
were identiﬁed by diagnosis. Psychotropic medications were
identiﬁed by the Redbook classiﬁcation system. RESULTS: There
was no difference in the probability of using pharmaceuticals or
the costs of pharmaceuticals among users between carve-outs
and non-carve-outs; although, predicted pharmaceutical expen-
ditures were lower for carve-outs ($4.80 versus $3.90). Carve-
outs had a lower probability of using inpatient care and
outpatient care. Carve-outs had higher costs for outpatient care
among users. The other differences were not statistically signiﬁ-
cant. Total predicted costs for carve-outs were about 28% lower
than for non-carve-outs. CONCLUSIONS: Behavioral carve-
outs have an incentive to shift usage away from mental health
ambulatory and hospital services and towards pharmaceuticals
because pharmaceutical usage is typically off the budget for
which they are held accountable. However, without very aggres-
sive utilization review, behavioral carve-outs may not have the
tools to inﬂuence pharmaceutical usage. This study ﬁnds that the
main effect of behavioral carve-outs is on the probably of inpa-
tient and outpatient behavioral health service usage.
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RISKS AND HEALTH CARE COSTS FROM THE MANAGED
CARE HEALTH RISK ASSESSMENT DATABASE
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OBJECTIVES: The association between mental distress and
health risks, protective health behavior (in the form of preven-
tive health screenings) and health care costs was evaluated
among a commercially insured, adult population. METHODS:
The sample contains 10,055 employees age 18–75, which is a
sub-set of the managed care, health risk assessment database
[MCHRA]. The MCHRA data was collected from 2000–2003.
Bi-variable analysis, logistic regression and general linear regres-
sion models were performed to evaluate the association between
mental distress (low, medium and high) and health risks, health
lifestyle, preventive health screenings, and health care costs.
RESULTS: Using multi-variable logistic regression models, those
with high mental distress were signiﬁcantly more likely to smoke
(adjusted odds ratio [AOR] 1.26, p = 0.0027), drink alcohol
(AOR 5.75, p < 0.0001), more likely to not wear a helmet when
biking (AOR, 1.37, p = 0.0188), more likely to be overweight
(AOR 1.21, p = 0.0350), more likely to feel a loss of self esteem
(AOR 8.86, p < 0.0001), more likely to have lost interest in life
(AOR 12.23, p < 0.0001), more likely to report depression (AOR
16.53, p < 0.0001), more likely to have sleep problems (AOR,
3.81, p < .0001) and less likely to be tested for colon cancer
through FOBT tests (AOR 1.429, p = .0006) or colonoscopy
(AOR 1.93, p < 0.0001). Those with mental distress were more
likely to have higher health care costs overall (>$1,700; F =
20.08, p < 0.0001). Health care cost areas associated with
disease classiﬁcations showed those with higher distress had
higher costs related to treatment of mental disorders (>$140; F
= 44.50, p < 0 .0001), the nervous system (>$70; F = 3.34, p =
0.0675) and respiratory system (>$120; F = 15.36, p < 0.0001).
CONCLUSIONS: The ﬁndings indicate a strong association
between mental distress, health risk and lifestyle, and preventive
health behavior and health care costs.
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OBJECTIVES: Unlike many other health care organizations,
central Texas veterans do not have day supply limits on med-
ications. Thus, the potential for medication over-adherence
exists. The objectives of this study were to: 1) examine the adher-
ence rate (AR) and medication possession ratio (MPR) among
veterans taking antipsychotics; 2) determine whether over-
adherence (AR > 1 or MPR > 1) exists among veterans taking
antipsychotics; and 3) evaluate factors related to over-adherence.
METHODS: Data were extracted from the Central Texas Vet-
erans Health Care System (CTVHCS) from September 1995—
October 2002 for continuously enrolled adult outpatients who
were on monotherapy, and had at least two prescriptions within
a year. Demographic and relevant clinical information, including
age, gender, ethnicity, psychiatric diagnoses, and antipsychotic
prescription medication information were collected. Subjects
were followed up to 12 months. RESULTS: Among the eligible
patients (N = 3252), the mean AR was 1.56 (sd = 2.58) and MPR
was 1.23 (sd = 0.75). Over one-half (54.4%) of the subjects were
over-adherent with ARs and MPRs > 1. For those over-adherent
patients, the mean AR was 2.38 (sd = 3.27) and MPR was 1.70
(sd = 0.71). Multiple logistic analyses revealed that schizophrenic
patients (OR = 1.241, p = 0.0085) were signiﬁcantly more likely
to be over-adherent (MPR > 1), while nonwhite (OR = 0.617, p
< 0.0001), depressed patients (OR = 0.801, p = 0.0085) and
atypical users (OR = 0.620, p < 0.0001) were signiﬁcantly less
likely to be over-adherent. A second logistic analysis to assess
individual antipsychotic agents showed that, compared to
haloperidol, quetiapine users (OR = 2.309, p = 0.0073) were sig-
niﬁcantly more likely to be over-adherent, and olanzapine (OR
